Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Age and Denosumab on Bone Formation
NCT02554695Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of denosumab in osteoporosis (3 arms), sponsored by Mayo Clinic. Primary endpoint: Gene expression changes in bone cells at 3 months. Started Oct 2015; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02554695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554695.